These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22965489)

  • 1. Evaluation of new bone formation in normal and osteoporotic rats with a 3-mm femur defect: functional assessment with dynamic PET-CT (dPET-CT) using 2-deoxy-2-[(18)F]fluoro-D-glucose ( (18)F-FDG) and (18)F-fluoride.
    Cheng C; Alt V; Dimitrakopoulou-Strauss A; Pan L; Thormann U; Schnettler R; Weber K; Strauss LG
    Mol Imaging Biol; 2013 Jun; 15(3):336-44. PubMed ID: 22965489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary evaluation of different biomaterials for defect healing in an experimental osteoporotic rat model with dynamic PET-CT (dPET-CT) using F-18-sodium fluoride (NaF).
    Cheng C; Alt V; Pan L; Thormann U; Schnettler R; Strauss LG; Schumacher M; Gelinsky M; Dimitrakopoulou-Strauss A
    Injury; 2014 Mar; 45(3):501-5. PubMed ID: 24332163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of F-18-sodium fluoride (NaF) dynamic PET-CT (dPET-CT) for defect healing: a comparison of biomaterials in an experimental osteoporotic rat model.
    Cheng C; Alt V; Pan L; Thormann U; Schnettler R; Strauss LG; Heinemann S; Schumacher M; Gelinsky M; Nies B; Dimitrakopoulou-Strauss A
    Med Sci Monit; 2014 Oct; 20():1942-9. PubMed ID: 25317537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of bone remodeling with (18)F-fluoride and correlation with the glucose metabolism measured by (18)F-FDG in lumbar spine with time in an experimental nude rat model with osteoporosis using dynamic PET-CT.
    Cheng C; Heiss C; Dimitrakopoulou-Strauss A; Govindarajan P; Schlewitz G; Pan L; Schnettler R; Weber K; Strauss LG
    Am J Nucl Med Mol Imaging; 2013; 3(2):118-28. PubMed ID: 23526138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics.
    Sachpekidis C; Goldschmidt H; Hose D; Pan L; Cheng C; Kopka K; Haberkorn U; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1343-53. PubMed ID: 24562650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of 18F-fluoride and 18F-FDG PET scans to assess fracture healing in a rat femur model.
    Hsu WK; Feeley BT; Krenek L; Stout DB; Chatziioannou AF; Lieberman JR
    Eur J Nucl Med Mol Imaging; 2007 Aug; 34(8):1291-301. PubMed ID: 17334765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients.
    Dimitrakopoulou-Strauss A; Pan L; Strauss LG
    Cancer Imaging; 2012 Sep; 12(1):283-9. PubMed ID: 23033440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment response evaluation with
    Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis.
    Frost ML; Fogelman I; Blake GM; Marsden PK; Cook G
    J Bone Miner Res; 2004 Nov; 19(11):1797-804. PubMed ID: 15476579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-fluoride PET imaging in a nude rat model of bone metastasis from breast cancer: Comparison with (18)F-FDG and bioluminescence imaging.
    Kang WJ; Song EH; Park JY; Park YJ; Cho A; Song HT
    Nucl Med Biol; 2015 Sep; 42(9):728-33. PubMed ID: 26068116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan.
    Damle NA; Bal C; Bandopadhyaya GP; Kumar L; Kumar P; Malhotra A; Lata S
    Jpn J Radiol; 2013 Apr; 31(4):262-9. PubMed ID: 23377765
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Mathavan N; Koopman J; Raina DB; Turkiewicz A; Tägil M; Isaksson H
    Acta Biomater; 2019 May; 90():403-411. PubMed ID: 30965143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-Fluoride PET/CT for detection of bone metastasis in patients with renal cell carcinoma: a pilot study.
    Sharma P; Karunanithi S; Chakraborty PS; Kumar R; Seth A; Julka PK; Bal C; Kumar R
    Nucl Med Commun; 2014 Dec; 35(12):1247-53. PubMed ID: 25171438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferret thoracic anatomy by 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) imaging.
    Wu A; Zheng H; Kraenzle J; Biller A; Vanover CD; Proctor M; Sherwood L; Steffen M; Ng C; Mollura DJ; Jonsson CB
    ILAR J; 2012; 53(1):E9-21. PubMed ID: 23382267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiautomatic region-of-interest validation at the femur in (18)F-fluoride PET/CT.
    Puri T; Blake GM; Curran KM; Carr H; Moore AE; Colgan N; O'Connell MJ; Marsden PK; Fogelman I; Frost ML
    J Nucl Med Technol; 2012 Sep; 40(3):168-74. PubMed ID: 22892275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer.
    Simoncic U; Perlman S; Liu G; Jeraj R
    Nucl Med Commun; 2015 Dec; 36(12):1174-80. PubMed ID: 26378490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study.
    Derlin T; Tóth Z; Papp L; Wisotzki C; Apostolova I; Habermann CR; Mester J; Klutmann S
    J Nucl Med; 2011 Jul; 52(7):1020-7. PubMed ID: 21680686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.